Web经验分享:medical oncology 08.22投稿,纯生信,一周后被拒,理由评分不高,整体拒稿率达到80%. 21 0. 2024-06-01 ms5000001799147083. 送外审50天了,状态还没有变。. 急啊. 30 2. 展开2条回复. 2024-10-15 146fda38m12暂无昵称. 审稿速度:2.0. WebThe current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular targeting agents. In addition, promising drug candidates under …
Current Drug Targets - SCI Journal
WebCurrent Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets ... WebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth … e and r general construction
CURRENT DRUG TARGETS_影响因子(IF)_中科院分区_SCI期刊投稿 …
WebSep 15, 2024 · Current Cancer Drug Targets在中科院分区中属于 大类学科 医学4区 ,在小类学科属于 肿瘤学 4区 。 在JCR分区中,该期刊属于 Q3 区,在242本肿瘤学期刊中 … WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and ... http://www.scizj.com/sci/14188.html csr blue board